SAADI RYAN H. (Chief Executive Officer) reported 1 transaction at TEVOGEN BIO HOLDINGS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 8/18/2025ACC: 0001062993-25-014586
DirectorOfficer10% Owner· Chief Executive Officer
Since Feb 2024
-20K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
20K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−20K
Price / share
—
Trade value
—
% of position
0.0%
8/15/2025
124.81M→124.79M
Total
Net shares
−20K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/15/2025 | G · Gift | −20K | — | — | 0.0% | 124.81M | 124.79M |
| Total | −20K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned193.92K
Total
193.92K indirect193.92K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 193.92K | Indirect |
| Total | 193.92K | 193.92K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported